News Release: July 30, 2025
1,3-Dibromoadamantane Price, Production, Latest News and Developments in 2025
1,3-Dibromoadamantane price trend and production News
The year 2025 has brought considerable changes to the global 1,3-Dibromoadamantane market. With a rapidly evolving industrial landscape, heightened regulatory frameworks, and fluctuating raw material availability, the industry continues to witness volatile but strategic shifts. As demand grows across sectors such as pharmaceuticals, specialty chemicals, and advanced materials, producers and traders are aligning their operations with current 1,3-Dibromoadamantane price trends and production dynamics.
1,3-Dibromoadamantane Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Between 2019 and 2024, the price of 1,3-Dibromoadamantane exhibited moderate to high volatility, influenced by both global supply chain disruptions and downstream demand. In 2019, average prices hovered around $4800/MT. However, entering 2020, prices climbed to $5300/MT, driven largely by rising demand from East Asian countries and limitations in bromine availability.
In 2021, pandemic-induced supply chain constraints caused price surges, touching nearly $5900/MT by Q4. The logistics bottlenecks and inconsistent availability of high-purity feedstocks significantly impacted global output, causing sporadic price hikes. This period marked the beginning of accelerated substitution of traditional raw materials with purer derivatives to meet pharmaceutical-grade quality, which added to cost pressure.
By 2022, as global logistics began to stabilize, the average price settled around $5500/MT, although raw material inflation and energy costs in Europe kept prices in the upper band in that region. In 2023, a brief decline was observed in Q1 and Q2 as inventories were adjusted across major consuming nations, bringing the price down to $5100/MT. However, renewed demand in electronics and specialty applications led to a quick rebound by Q3 2023, bringing prices back to $5700/MT.
Throughout 2024, a mix of new production capacities in Asia and geopolitical tensions in trade routes affected pricing. The year ended with an average global price of approximately $5400/MT. Emerging trends in contract manufacturing and consistent pharmaceutical demand from Europe kept the price trajectory largely stable.
Factors impacting these price trends included:
- Raw material volatility, especially bromine and adamantane derivatives
- Fluctuating demand in downstream sectors
- Trade policies and tariffs on chemical intermediates
- Shift in consumer preference toward higher purity grades
- Energy price surges affecting production costs in Europe and North America
- Logistics and freight rate variability
1,3-Dibromoadamantane Price Trend Quarterly Update in $/MT (Estimated for 2025)
As of 2025, the quarterly 1,3-Dibromoadamantane price trend reflects a stable yet upward-moving trajectory as follows:
- Q1 2025: $5500/MT – The first quarter witnessed moderate price increases due to tightening bromine supply in China and procurement rush by South Korean and Indian buyers ahead of the financial year end.
- Q2 2025: $5650/MT – Prices climbed slightly amid production shutdowns in Southeast Asia caused by regulatory inspections.
- Q3 2025: $5800/MT – Mid-year demand spike from pharmaceutical and polymer industries pushed prices higher, despite some new supply entering the market.
- Q4 2025: $5950/MT (estimated) – Anticipated year-end bulk orders and restricted exports from a few producers are likely to support a further price increase.
This quarterly breakdown shows that 1,3-Dibromoadamantane price news is influenced strongly by regional supply conditions, seasonality in demand, and manufacturing interruptions across production clusters.
Global 1,3-Dibromoadamantane Import-Export Business Overview (2025)
In 2025, the global import-export dynamics of 1,3-Dibromoadamantane are undergoing notable realignment as new production bases emerge and traditional exporters recalibrate their market strategies.
Asia-Pacific Region: The Powerhouse of Production and Export
China continues to lead global production volumes of 1,3-Dibromoadamantane, with its advanced bromination capabilities and established raw material base. Chinese manufacturers account for over 45% of global supply, with significant export volumes to India, Japan, Germany, and the United States. Throughout 2025, a major shift has been observed toward long-term bilateral trade agreements between Chinese producers and South Asian buyers, helping streamline export volumes and reducing customs-induced delays.
South Korea and India, while still dependent on imports, have started to explore local production. India, in particular, is incentivizing domestic chemical manufacturing under its “Make in India” program, which is expected to reduce its 1,3-Dibromoadamantane imports by 10% by the end of 2025.
Europe: Stable Demand, Premium Imports
Europe remains a premium importer, especially for pharmaceutical-grade 1,3-Dibromoadamantane. Germany, Switzerland, and the Netherlands lead the region in terms of demand. Due to the strict regulatory norms and quality standards in Europe, the region primarily imports high-purity grades, often at a premium price ranging between $6100/MT and $6500/MT. Import volumes, however, remained flat in 2025 due to slower economic growth and post-inventory corrections.
North America: Dual Strategy of Import and Production
The United States has balanced both domestic production and imports to manage supply risk. Texas and Louisiana host a few small to mid-sized specialty chemical manufacturers who contribute to local supply. However, fluctuations in bromine pricing and labor shortages have led to temporary drops in production capacity, prompting the U.S. to ramp up imports from China and Germany. 1,3-Dibromoadamantane sales volume in the U.S. recorded a 6% year-on-year increase as of mid-2025.
Canada continues to rely entirely on imports, primarily from the U.S. and China, due to limited domestic infrastructure for this compound. The North American Free Trade framework has facilitated smoother cross-border flows, with average CIF import prices at approximately $5900/MT.
Middle East & Africa: Emerging Import Hubs
The Middle East, especially countries like the UAE and Saudi Arabia, has started to show increasing demand for 1,3-Dibromoadamantane in research and specialty chemical sectors. Although production remains negligible, the region has emerged as a key import hub. Dubai has particularly established itself as a re-export center due to favorable port infrastructure and tax regimes.
Africa, on the other hand, remains a low-volume consumer. South Africa imports limited quantities for niche pharmaceutical and academic research, with prices often ranging higher due to added logistics costs.
Latin America: Rising Demand, Dependent Supply
Latin America’s demand for 1,3-Dibromoadamantane, while relatively modest, has been growing steadily. Brazil and Mexico are the largest importers in the region. The increase in pharmaceutical manufacturing in Brazil has resulted in higher 1,3-Dibromoadamantane sales volume in the region. However, due to infrastructure limitations and volatile exchange rates, imported prices are often 8-12% higher than the global average.
Trade Challenges and Compliance
Regulatory shifts have also impacted the 1,3-Dibromoadamantane import-export landscape. Updated REACH regulations in Europe and tightening safety standards in ASEAN nations have compelled manufacturers to reassess product certifications. Meanwhile, environmental compliance during production and transport remains a critical factor influencing global trade routes.
Production Forecasts and Logistics Trends
1,3-Dibromoadamantane production is expected to grow by 6% globally in 2025, driven by capacity additions in China, India, and expansion plans by select manufacturers in Eastern Europe. Logistics remains a key concern, particularly in the Red Sea and Suez Canal regions, which have experienced increased transit costs and delay risk due to geopolitical disruptions.
Overall, the 1,3-Dibromoadamantane price trend and trade outlook for 2025 presents a cautiously optimistic scenario. As market stakeholders adapt to regional complexities and emerging demand nodes, the focus will remain on cost efficiency, supply security, and regulatory compliance.
For more details on price analytics, production forecasts, and custom insights, request a sample from the official source here:
https://datavagyanik.com/reports/13-dibromoadamantane-market/
1,3-Dibromoadamantane Production Trends by Geography (2025)
The global production landscape of 1,3-Dibromoadamantane in 2025 is defined by strategic manufacturing locations, access to bromine feedstocks, labor cost efficiencies, and increasing compliance with quality standards for pharmaceutical and specialty chemical applications. Production trends show a growing shift toward Asia, with select developments in North America and Europe. The following is a comprehensive overview of production activities across key geographies.
China
China remains the largest producer of 1,3-Dibromoadamantane globally, owing to its established chemical manufacturing infrastructure and abundant availability of bromine and intermediate compounds. Chinese producers benefit from vertical integration and cost-effective labor, which help them maintain a competitive edge in global pricing. Most Chinese production units are concentrated in provinces like Shandong and Jiangsu, where dedicated chemical industrial parks provide logistical and environmental benefits. Additionally, Chinese producers are expanding capacity in response to growing global demand, especially from India, the US, and Europe. Production units have also upgraded their purification processes to comply with export regulations and attract high-margin pharmaceutical buyers.
India
India is witnessing a gradual rise in domestic production of 1,3-Dibromoadamantane, driven by policy incentives under the government’s “Make in India” initiative. While the country has been primarily an importer, 2025 marks a turning point as new facilities in Gujarat and Maharashtra come online with pilot-scale and commercial-scale capacities. These facilities are leveraging technology transfers and joint ventures with East Asian partners. Indian manufacturers are currently focused on developing pharmaceutical-grade and intermediate-grade variants to cater to local and Southeast Asian demand. Capacity is expected to grow by 20% year-on-year through 2026.
United States
In North America, the United States hosts several small to mid-scale specialty chemical manufacturing units producing 1,3-Dibromoadamantane. These are primarily located in chemical hubs such as Texas and Louisiana, where access to advanced bromination technology and regulatory infrastructure supports high-purity production. However, labor shortages and rising production costs have capped large-scale expansion. The U.S. market mostly caters to domestic demand, with limited export capacity. Some firms focus on high-purity grades suited for research and development in the pharmaceutical sector. Sustainability regulations have also prompted U.S. manufacturers to adopt greener production practices.
Germany
Germany represents a high-precision production base for 1,3-Dibromoadamantane, where chemical producers focus on quality, purity, and environmental compliance. While production volumes are modest compared to Asia, German firms produce some of the highest-purity variants targeted at pharmaceutical and material sciences applications. Production facilities in cities like Leverkusen and Ludwigshafen are tightly integrated into advanced chemical parks with access to robust R&D infrastructure. Germany’s domestic demand is largely met through local production, with additional imports supplementing peak demand periods.
Japan and South Korea
Japan and South Korea maintain small but technologically advanced production units for 1,3-Dibromoadamantane. These countries specialize in high-value segments, including custom synthesis and advanced formulations. Japanese producers, especially, have focused on integrating sustainable chemistry in their bromination processes, resulting in lower emissions and higher energy efficiency. South Korea, on the other hand, supports production through government R&D funding and export-focused strategies. Both countries act more as exporters of specialized, high-purity variants rather than bulk manufacturers.
Eastern Europe
Countries like Poland and Hungary are emerging as niche players in the production of specialty chemicals, including 1,3-Dibromoadamantane. These nations benefit from lower labor costs compared to Western Europe while maintaining compliance with EU quality and safety standards. Eastern European producers often engage in contract manufacturing for Western European clients, and output is generally directed toward intra-European trade. This region is expected to see moderate production growth through 2025, especially in pharmaceutical supply chains.
Middle East
Although still at a nascent stage, the Middle East is exploring production feasibility for 1,3-Dibromoadamantane due to rising demand in the GCC region and the availability of bromine resources in countries like Jordan. The UAE and Saudi Arabia have initiated studies into chemical diversification, and pilot-scale facilities may emerge in the coming years. However, full-scale commercial production is not expected before 2026.
Conclusion
Global 1,3-Dibromoadamantane production is being reshaped by regional policies, cost pressures, and technological investments. Asia, particularly China and India, continues to dominate production, while the U.S., Germany, and Japan maintain leadership in quality and niche segments. The growing demand across pharmaceuticals and specialty applications is pushing all regions to invest in both quantity and quality, ensuring diversified supply in the global market.
1,3-Dibromoadamantane Market Segmentation
The market for 1,3-Dibromoadamantane is segmented based on application, grade, end-use industry, and region. These segments define how the product is distributed, priced, and consumed across the global chemical and pharmaceutical landscape.
Market Segments
- By Application
- Pharmaceutical Intermediates
- Organic Synthesis
- Research & Development
- Polymer Modifiers
- Specialty Chemicals
- By Grade
- Industrial Grade
- Pharmaceutical Grade
- Research Grade
- By End-Use Industry
- Pharmaceuticals
- Biotechnology
- Chemical Manufacturing
- Academia and Research Institutes
- Polymers and Materials
- By Region
- Asia-Pacific
- North America
- Europe
- Latin America
- Middle East and Africa
Explanation of Leading Segments
Pharmaceutical Intermediates – Dominant Application Segment
1,3-Dibromoadamantane is primarily used as a key intermediate in the synthesis of complex pharmaceutical compounds, especially antiviral and anticancer drugs. In 2025, this segment continues to lead the market, accounting for over 50% of total global consumption. The compound’s stability and structural rigidity make it suitable for drug design processes. Growing global investment in novel drug discovery and generics manufacturing is further driving demand. India, China, and the U.S. represent the strongest consumption hubs for this application.
Pharmaceutical Grade – Highest Value Grade Segment
Pharmaceutical-grade 1,3-Dibromoadamantane commands the highest market price due to the extensive purification, compliance, and certification requirements. In 2025, this grade is seeing increased demand from regulated markets like the EU, U.S., and Japan, where Good Manufacturing Practices (GMP) are strictly enforced. The pharmaceutical-grade segment is also attracting investment in production upgrades and analytical quality control systems, further expanding its footprint.
Chemical Manufacturing – Expanding End-Use Segment
While pharmaceutical applications dominate, the use of 1,3-Dibromoadamantane in broader chemical manufacturing processes is steadily increasing. It acts as a versatile brominated building block in custom synthesis. Specialty chemical producers are utilizing this compound in the development of flame retardants, high-performance resins, and materials for electronic components. The rising focus on functionalized brominated compounds is encouraging adoption beyond just medical applications.
Asia-Pacific – Leading Regional Market
The Asia-Pacific region, led by China and India, dominates the global market for 1,3-Dibromoadamantane in terms of both production and consumption. Rapid industrial growth, cost-effective manufacturing, and a well-established pharmaceutical export framework give the region a strong advantage. In 2025, Asia-Pacific accounts for more than 60% of the market volume. Southeast Asian countries like Vietnam and Thailand are also emerging as new demand centers.
North America – Premium Market with Steady Demand
North America, especially the United States, maintains steady demand for high-purity and research-grade 1,3-Dibromoadamantane. The region’s well-developed pharmaceutical and academic research ecosystem supports consistent consumption. Due to stringent FDA guidelines, most usage is concentrated in certified and monitored applications. Pricing is typically higher in this region due to quality standards and limited local production capacity.
Europe – Regulated and Specialized Segment
Europe remains a specialized and regulated market. Germany, France, and Switzerland are major consumers, particularly in pharmaceutical research and fine chemical manufacturing. EU regulatory frameworks require manufacturers and importers to ensure complete compliance, making Europe a market for premium-grade, certified products. The region is also known for research-driven demand from universities and biotech labs.
Research & Development – Niche but Growing Segment
Academic institutions and contract research organizations represent a small but essential segment for 1,3-Dibromoadamantane. As universities increasingly collaborate with biotech startups and pharmaceutical firms, the demand for small-scale, high-purity chemicals has grown. This segment prefers flexible packaging and consistent availability, often sourced from specialized suppliers in Europe or North America.